Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Primary Efficacy Endpoint and Safety Results of Ibalizumab in a Phase 3 Study of Heavily Treatment-Experienced Patients With Multidrug-Resistant Human Immunodeficiency Virus-1 Infection

Jacob Lalezari,W. Jeffery Fessel,Shannon Schrader,Princy Kumar,Gary Richmond,Christian Marsolais,Steven P. Weinheimer,Stanley Lewis

Open Forum Infectious Diseases（2016）

Cited 0|Views37
No score
Key words
human immunodeficiency virus-1 infection,ibalizumab,virus-1 infection,efficacy,treatment-experienced,multidrug-resistant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined